Literature DB >> 19623048

Discontinuation of continuous renal replacement therapy: a post hoc analysis of a prospective multicenter observational study.

Shigehiko Uchino1, Rinaldo Bellomo, Hiroshi Morimatsu, Stanislao Morgera, Miet Schetz, Ian Tan, Catherine Bouman, Ettiene Macedo, Noel Gibney, Ashita Tolwani, Heleen Oudemans-van Straaten, Claudio Ronco, John A Kellum.   

Abstract

OBJECTIVES: To describe current practice for the discontinuation of continuous renal replacement therapy in a multinational setting and to identify variables associated with successful discontinuation. The approach to discontinue continuous renal replacement therapy may affect patient outcomes. However, there is lack of information on how and under what conditions continuous renal replacement therapy is discontinued.
DESIGN: Post hoc analysis of a prospective observational study.
SETTING: Fifty-four intensive care units in 23 countries. PATIENTS: Five hundred twenty-nine patients (52.6%) who survived initial therapy among 1006 patients treated with continuous renal replacement therapy.
INTERVENTIONS: None.
MEASUREMENTS AND MAIN RESULTS: Three hundred thirteen patients were removed successfully from continuous renal replacement therapy and did not require any renal replacement therapy for at least 7 days and were classified as the "success" group and the rest (216 patients) were classified as the "repeat-RRT" (renal replacement therapy) group. Patients in the "success" group had lower hospital mortality (28.5% vs. 42.7%, p < .0001) compared with patients in the "repeat-RRT" group. They also had lower creatinine and urea concentrations and a higher urine output at the time of stopping continuous renal replacement therapy. Multivariate logistic regression analysis for successful discontinuation of continuous renal replacement therapy identified urine output (during the 24 hrs before stopping continuous renal replacement therapy: odds ratio, 1.078 per 100 mL/day increase) and creatinine (odds ratio, 0.996 per [micro]mol/L increase) as significant predictors of successful cessation. The area under the receiver operating characteristic curve to predict successful discontinuation of continuous renal replacement therapy was 0.808 for urine output and 0.635 for creatinine. The predictive ability of urine output was negatively affected by the use of diuretics (area under the receiver operating characteristic curve, 0.671 with diuretics and 0.845 without diuretics).
CONCLUSIONS: We report on the current practice of discontinuing continuous renal replacement therapy in a multinational setting. Urine output at the time of initial cessation of continuous renal replacement therapy was the most important predictor of successful discontinuation, especially if occurring without the administration of diuretics.

Entities:  

Mesh:

Year:  2009        PMID: 19623048     DOI: 10.1097/CCM.0b013e3181a38241

Source DB:  PubMed          Journal:  Crit Care Med        ISSN: 0090-3493            Impact factor:   7.598


  58 in total

1.  Urinary biomarkers and renal recovery in critically ill patients with renal support.

Authors:  Nattachai Srisawat; Xiaoyan Wen; Minjae Lee; Lan Kong; Michele Elder; Melinda Carter; Mark Unruh; Kevin Finkel; Anitha Vijayan; Mohan Ramkumar; Emil Paganini; Kai Singbartl; Paul M Palevsky; John A Kellum
Journal:  Clin J Am Soc Nephrol       Date:  2011-07-14       Impact factor: 8.237

2.  Initiation and Cessation Timing of Renal Replacement Therapy in Patients with Type 1 Cardiorenal Syndrome: An Observational Study.

Authors:  Buyun Wu; Wenyan Yan; Xing Li; Xiangqing Kong; Xiangbao Yu; Yamei Zhu; Changying Xing; Huijuan Mao
Journal:  Cardiorenal Med       Date:  2017-01-20       Impact factor: 2.041

3.  Transient and persistent acute kidney injury in acute liver failure.

Authors:  Silvia Coelho; José Nuno Fonseca; Joana Gameiro; Sofia Jorge; José Velosa; José António Lopes
Journal:  J Nephrol       Date:  2018-12-19       Impact factor: 3.902

Review 4.  [New KDIGO guidelines on acute kidney injury. Practical recommendations].

Authors:  A Zarbock; S John; A Jörres; D Kindgen-Milles
Journal:  Anaesthesist       Date:  2014-07       Impact factor: 1.041

Review 5.  The Japanese clinical practice guideline for acute kidney injury 2016.

Authors:  Kent Doi; Osamu Nishida; Takashi Shigematsu; Tomohito Sadahiro; Noritomo Itami; Kunitoshi Iseki; Yukio Yuzawa; Hirokazu Okada; Daisuke Koya; Hideyasu Kiyomoto; Yugo Shibagaki; Kenichi Matsuda; Akihiko Kato; Terumasa Hayashi; Tomonari Ogawa; Tatsuo Tsukamoto; Eisei Noiri; Shigeo Negi; Koichi Kamei; Hirotsugu Kitayama; Naoki Kashihara; Toshiki Moriyama; Yoshio Terada
Journal:  Clin Exp Nephrol       Date:  2018-10       Impact factor: 2.801

Review 6.  Discontinuation of renal replacement therapy in critically ill patients with severe acute kidney injury: predictive factors of renal function recovery.

Authors:  Helmut Schiffl
Journal:  Int Urol Nephrol       Date:  2018-08-02       Impact factor: 2.370

Review 7.  [Extracorporeal renal replacement therapy in acute kidney injury : Recommendations from the renal section of the DGIIN, ÖGIAIN and DIVI].

Authors:  V Schwenger; D Kindgen-Milles; C Willam; A Jörres; W Druml; D Czock; S J Klein; M Oppert; M Schmitz; J T Kielstein; A Zarbock; M Joannidis; S John
Journal:  Med Klin Intensivmed Notfmed       Date:  2018-03-15       Impact factor: 0.840

8.  Impact of early parenteral nutrition on metabolism and kidney injury.

Authors:  Jan Gunst; Ilse Vanhorebeek; Michaël P Casaer; Greet Hermans; Pieter J Wouters; Jasperina Dubois; Kathleen Claes; Miet Schetz; Greet Van den Berghe
Journal:  J Am Soc Nephrol       Date:  2013-03-28       Impact factor: 10.121

9.  Neutrophil gelatinase-associated lipocalin clearance during veno-venous continuous renal replacement therapy in critically ill patients.

Authors:  Hilde R H de Geus; Michiel G H Betjes; Jan Bakker
Journal:  Intensive Care Med       Date:  2010-08-19       Impact factor: 17.440

10.  Recently published papers: renal support in acute kidney injury - is low dose the new high dose?

Authors:  Yadullah Syed; James A P Tomlinson; Lui G Forni
Journal:  Crit Care       Date:  2009-12-11       Impact factor: 9.097

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.